Parker Geoffrey M. sold $49K of ALLO
Parker Geoffrey M. (CHIEF FINANCIAL OFFICER) sold 36,342 shares of Allogene Therapeutics, Inc. (ALLO) at $1.34 on 2026-10-21.
How this was made
The 30-second read
Why it matters
The CFO's sale is modest relative to total holdings, likely causing limited market reaction.
Market read
Small insider sale with minimal price impact; traders may note but no immediate action required.
What to watch
CFO's overall large stake and lack of 10b5-1 plan suggest personal liquidity need rather than loss of confidence.
Background
Form 4 filings disclose insider transactions and are primary sources for such events.
Ticker impact
CFO Parker Geoffrey M. sold 36,342 shares of Allogene Therapeutics for $48.7K in a Form 4 filing.
likely modest pressure as market prices in the insider sale.
The sale is small relative to holdings and typical for a 10b5-1 plan, but signals potential insider intent.
Market effects
Limited impact on biotech sector; similar insider sales are common.
No regional effect.
Minimal global relevance.
Counterpoint
The sale may be routine and not indicative of company outlook.
Key entities
- CompanyAllogene Therapeutics, Inc.
Biotech firm developing cell therapies.
- IndividualParker Geoffrey M.
Chief Financial Officer of Allogene Therapeutics.
